Richard A. Flavell, PhD, Sterling Professor of Immunobiology and a Howard Hughes Medical Institute investigator, has been named a Distinguished Fellow by the American Association of Immunologists (AAI), which calls this designation one of the highest honors that AAI bestows.
Flavell also is a fellow of the Royal Society and a member of the National Academy of Sciences, EMBO, and the National Academy of Medicine. His laboratory uses transgenic and gene-targeted mice to study innate and adaptive immunity, T cell tolerance, and activation in immunity and autoimmunity, apoptosis, and regulation of T cell differentiation.
“I am honored to be recognized in this way by the AAI, the premier immunology society,” he says.
According to AAI, the honor recognizes "active, long-term members (25 or more years) who have demonstrated one or more of the following: excellence in research accomplishment in the field of immunology; exceptional leadership to the immunology community in academia, foundations, nonprofits, industry, or government at a national or international level; notable distinction as an educator."
Flavell is one of 20 scientists who have been designated Distinguished Fellows for 2020.